力世紀(00860.HK)擬折價19.30%配股淨籌4.86億港元 午後復牌
格隆匯12月7日丨力世紀(00860.HK)宣佈,於2020年12月7日,公司與不少於6名認購方訂立認購協議,認購方已同意認購,而公司已同意按認購價向認購方配發及發行合共約10.67億股新股份。
認購股份佔公司現有已發行股本約14.88%,及佔經擴大後股本約12.95%。認購價每股0.46港元,較12月4日收市價0.57港元折讓約19.30%。
認購事項所得款項淨額預計約為4.86億港元,其中約90%將用於未來潛在收購或投資新能源汽車相關業務或技術;及約10%將用作一般營運資金。
此外,公司股份自12月7日下午1時正起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.